Back to Search
Start Over
A Phase 1 Study of Tasquinimod in Patients with Relapsed or Refractory Multiple Myeloma
- Source :
- Blood; November 2020, Vol. 136 Issue: Supplement 1 p17-18, 2p
- Publication Year :
- 2020
-
Abstract
- Vogl: Active Biotech: Consultancy, Research Funding; Janssen: Consultancy; Karyopharm: Consultancy; Takeda: Consultancy; Celgene: Consultancy; Oncopeptides: Consultancy; MorphoSys: Consultancy. Nefedova:Active Biotech: Consultancy, Research Funding. Bondesson:Active Biotech: Current Employment. Eriksson:Active Biotech: Current Employment. Tuvesson:Active Biotech: Current Employment.Tasquinimod for multiple myeloma
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 136
- Issue :
- Supplement 1
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs54547814
- Full Text :
- https://doi.org/10.1182/blood-2020-137482